SCHEMBL10074607

SCHEMBL10074607

CCCCC(CC)CN(CC(CC)CCCC)C(=O)c1cc(N/N=C(/C(C)=O)C(=O)Nc2ccc(NC(=O)/C(=N\Nc3cc(C(=O)OC)ccc3C(=O)OC)C(C)=O)cc2)cc(C(=O)N(CC(CC)CCCC)CC(CC)CCCC)c1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 15/20 0.39
ALDH1A1 P00352 13/20 0.39
HPGD P15428 4/20 0.39
LMNA P02545 3/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
KMT2A Q03164 1/20 0.38
GLA P06280 2/20 0.37
GAA P10253 1/20 0.37
TSHR P16473 2/20 0.35
MAPK1 P28482 2/20 0.35
HSD17B10 Q99714 4/20 0.35
ERAP2 Q6P179 2/20 0.35
LNPEP Q9UIQ6 2/20 0.35
CASP1 P29466 2/20 0.35
CASP7 P55210 1/20 0.35
POLB P06746 1/20 0.35
MAPT P10636 4/20 0.34
NPC1 O15118 2/20 0.32
RAB9A P51151 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14947842 0.84 MAPT (0.34) KDM4EALDH1A1LMNAL3MBTL1KMT2A
SCHEMBL14950965 0.83 POLB (0.40) KDM4EALDH1A1LMNAKMT2AGAA
SCHEMBL14950977 0.83 ALDH1A1 (0.53) KDM4EALDH1A1HPGDLMNAL3MBTL1
SCHEMBL14947835 0.81 KMT2A (0.39) KDM4EALDH1A1LMNAL3MBTL1KMT2A
SCHEMBL16523 0.79 KDM4E (0.52) KDM4EALDH1A1HPGDLMNAL3MBTL1
SCHEMBL10052753 0.79 KDM4E (0.52) KDM4EALDH1A1HPGDLMNAL3MBTL1
SCHEMBL18746175 0.79 ALDH1A1 (0.47) KDM4EALDH1A1HPGDLMNAL3MBTL1
SCHEMBL14950001 0.76 KDM4E (0.47) KDM4EALDH1A1HPGDLMNAL3MBTL1
SCHEMBL14950100 0.76 KDM4E (0.45) KDM4EALDH1A1HPGDLMNAL3MBTL1
SCHEMBL12677172 0.75 KDM4E (0.48) KDM4EALDH1A1HPGDLMNAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8815485-B2 Azo compound, pigment dispersant containing the azo compound, pigment composition, pigment dispersion, and toner CANON KABUSHIKI KAISHA (JP) 2014-08-26 US disclosed
US-20130122413-A1 AZO COMPOUND, PIGMENT DISPERSANT CONTAINING THE AZO COMPOUND, PIGMENT COMPOSITION, PIGMENT DISPERSION, AND TONER CANON KABUSHIKI KAISHA (JP) 2013-05-16 US disclosed
WO-2012026378-A1 AZO COMPOUND, PIGMENT DISPERSANT CONTAINING THE AZO COMPOUND, PIGMENT COMPOSITION, PIGMENT DISPERSION, AND TONER CANON KABUSHIKI KAISHA (JP) 2012-03-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130122413-A1 AZO COMPOUND, PIGMENT DISPERSANT CONTAINING THE AZO COMPOUND, PIGMENT COMPOSITION, PIGMENT DISPERSION, AND TONER TYR, CRY1, MITF KDM4E 1872/4885ALDH1A1 1826/4885HPGD 1627/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.